A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
Kathleen N. Moore, David S. Hong, Manish R. Patel, Shubham Pant, Susanna V. Ulahannan, Suzanne F. Jones, Funda Meric‐Bernstam, Judy S. Wang, Raid Aljumaily, Erika Hamilton, Erika S. Wittchen, Xuejing Wang, Aimee Bence Lin, Johanna C. Bendell
Topics & Concepts
MedicineCetuximabPemetrexedCisplatinOncologyCancerAdverse effectInternal medicinePhases of clinical researchChemotherapyPharmacologyColorectal cancerLung Cancer Treatments and MutationsMelanoma and MAPK PathwaysPARP inhibition in cancer therapy